Icosavax
Icosavax is an American biotechnology company based in Seattle, Washington.
History
Icosavax was founded in 2017 to advance virus-like particle (VLP) technology from the Institute for Protein Design at the University of Washington with the goal to discover, develop, and commercialize vaccines against infectious diseases.1)
Activities
Icosavax is developing products for SARS-CoV-2, RSV and human metapneumovirus (hMPV).
External links
1)
Corporate profile. Icosavax. Retrieved March 12, 2023, from http://archive.today/2023.03.12-054948/https://ir.icosavax.com/